The episode discusses key breast cancer trials presented at the 2026 ASCO Annual Meeting.
For this week’s VJOncology podcast, we bring you highlights in breast cancerfrom the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting inChicago, IL. Join Oleg Gluz of Evang. Krakenhaus “Bethesda” Klinik, Jana deBoniface of the Karolinska Institutet, Peter Schmid of Queen Mary University ofLondon and Erika Hamilton of the Sarah Cannon Research Institute as theydiscuss key trials and what this means for clinical practice. They explore pooledanalysis from the ADAPT and PlanB trials, results from the SENOMAC trial ofaxillary lymph node dissection omission, menopausal status data from the lidERAtrial, final analysis from KEYNOTE-522 and subgroup analyses fromHER2CLIMB-05.
Explore listener stats, chart rankings, contacts and more on the VJOncology Podcast podcast page.